These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 250623)
41. [Infusion and transfusion therapy in polytraumatized patients]. Enrichens F; Sciascia C; Festa T; Mao P; Benedetto G; Manconi P; Aiello D; Pessione E; Rozzio G; Bossotti M Minerva Med; 1985 Jan; 76(3-4):73-84. PubMed ID: 3974924 [TBL] [Abstract][Full Text] [Related]
42. [Transfusion-infusion aid to the wounded and sick]. Ryzhkov SV; Vetrov SI Klin Med (Mosk); 1975 May; 53(5):25-9. PubMed ID: 1097819 [No Abstract] [Full Text] [Related]
43. [Principles of infusion-transfusion therapy in operations on the lungs]. Dolina OA Khirurgiia (Mosk); 1987 Jul; (7):85-90. PubMed ID: 3657007 [No Abstract] [Full Text] [Related]
44. [Changes in blood volume in relation to the administration of a plasma substitute ("Emagel"). Research with erythrocytes labeled with Cr51]. Pannacciulli E; Ajmar F Minerva Chir; 1966 Jan; 21(2):67-70. PubMed ID: 5930396 [No Abstract] [Full Text] [Related]
46. [Role of repeated infusions of polyglucin in the treatment of postresuscitation states after fatal blood loss in dogs]. Kozhura VL; Trubina IE Biull Eksp Biol Med; 1982 Feb; 93(2):23-5. PubMed ID: 7066519 [No Abstract] [Full Text] [Related]
47. [The use of erythrocytes washed with the plasma substitute TsOLIPK No. 8 solution]. Polishchuk RS Probl Gematol Pereliv Krovi; 1965 Nov; 10(11):39-44. PubMed ID: 5896009 [No Abstract] [Full Text] [Related]
48. [Extracorporal methods in transfusiology]. Ragimov AA; Solov'eva IN Klin Med (Mosk); 2005; 83(4):4-8. PubMed ID: 15941134 [No Abstract] [Full Text] [Related]
49. [Comparative characteristics of an erythrocyte suspension with different plasma-substitute solutions]. Poliakova LP; Agranenko VA; Suvorova IA; Golubeva VL; Borzova LV Probl Gematol Pereliv Krovi; 1980 Jan; 25(1):11-5. PubMed ID: 7367394 [No Abstract] [Full Text] [Related]
51. [Transfusion therapy depending on the severity and period of the course of burn disease]. Kozlov AI; Manzharov NV Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):35-8. PubMed ID: 461394 [No Abstract] [Full Text] [Related]
52. [Experimental studies of the possibility of use of stroma-free hemoglobin solution]. Rudowski W; Schier J; Daszynski J; Kostrzewska E Minerva Med; 1973 Feb; 64(9):447-52. PubMed ID: 4694768 [No Abstract] [Full Text] [Related]
56. [Pathogenetic principle of substantiation of indications and programs for transfusion therapy in surgical practice]. Golovin GV; Dutkevich IG; Mozhaev VI; Dekster BG Vestn Khir Im I I Grek; 1985 Jun; 134(6):122-6. PubMed ID: 4049653 [TBL] [Abstract][Full Text] [Related]
57. [Experimental study of a hemoglobin solution as a blood substitute]. Sztuka JC; Bleser F; Gaillard S; Benichoux R Anesth Analg (Paris); 1976; 33(2):231-8. PubMed ID: 1008272 [No Abstract] [Full Text] [Related]
58. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion]. Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944 [TBL] [Abstract][Full Text] [Related]
59. [Gas exchange characteristics in blood loss compensation after lung resection]. Pavlov VA Grudn Khir; 1981; (2):67-70. PubMed ID: 6783479 [No Abstract] [Full Text] [Related]
60. [Transfusion of blood and plasma substitutes; risks, value and limitation]. REISSIGL H Chirurg; 1954 Dec; 25(12):529-32. PubMed ID: 14352366 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]